MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-25-2026
Edwards Lifesciences Corporation DPO Ratio 2011-2026 | EW
Annual DPO Ratio Edwards Lifesciences Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 58.1 | 62.7 | 72.5 | 102 | 58.6 | 63.7 | 59.1 | 52.1 | 48.6 | 44.4 | 37.8 | 34 | 33.8 | 55.1 | 63.3 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 102 | 33.8 | 56.4 |
Quarterly DPO Ratio Edwards Lifesciences Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 43.2 | 44.3 | 55.9 | - | 62.2 | 66 | 63.4 | - | 69.8 | 66.4 | 53 | - | 27.9 | 26.9 | 55.4 | - | 41.6 | 40.3 | 53.9 | - | 63.8 | 75.3 | 64.9 | - | 56.3 | 54.1 | 61.9 | - | 54.4 | 49.7 | 49 | - | 49.9 | 50.4 | 45.2 | - | 44 | 43.8 | 40.7 | - | 39.8 | 36.8 | 41 | - | 31.6 | 35.1 | 33.3 | - | 17.2 | - | 28.2 | - | - | - | 30.5 | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 75.3 | 17.2 | 47.9 |
DPO Ratio of other stocks in the Medical devices industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Abbott Laboratories
ABT
|
79.7 | $ 104.93 | 0.34 % | $ 183 B |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
81.3 | - | - | $ 1.77 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
40.1 | - | - | $ 3.31 B | USA |
 |
Lianluo Smart Limited
LLIT
|
10.5 | - | 24.59 % | $ 44.8 M |  China |
 |
Dynatronics Corporation
DYNT
|
52.2 | - | 14.99 % | $ 929 K | USA |
 |
Aziyo Biologics
AZYO
|
286 | - | 1.37 % | $ 20.5 M | USA |
 |
Align Technology
ALGN
|
33.7 | $ 167.25 | -5.68 % | $ 12.5 B | USA |
 |
Acutus Medical
AFIB
|
92.7 | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
23.1 | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
224 | - | -5.86 % | $ 30.6 M | USA |
 |
Accuray Incorporated
ARAY
|
49.2 | $ 0.4 | 6.74 % | $ 41.1 M | USA |
 |
Alphatec Holdings
ATEC
|
73.8 | $ 11.08 | -3.82 % | $ 1.66 B | USA |
 |
Conformis
CFMS
|
50.4 | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
81.8 | - | 0.15 % | $ 844 M | USA |
 |
Second Sight Medical Products
EYES
|
29.6 | - | -0.97 % | $ 54.4 M | USA |
 |
Apollo Endosurgery
APEN
|
63.6 | - | - | $ 475 M | USA |
 |
Bruker Corporation
BRKR
|
46.4 | $ 34.41 | -2.65 % | $ 5.13 K | USA |
 |
Boston Scientific Corporation
BSX
|
61.7 | $ 69.2 | -1.38 % | $ 102 B | USA |
 |
Avinger
AVGR
|
45.5 | - | -20.74 % | $ 369 K | USA |
 |
CryoLife, Inc.
CRY
|
41.1 | - | -4.14 % | $ 702 M | USA |
 |
ClearPoint Neuro
CLPT
|
33.2 | $ 9.17 | -2.34 % | $ 260 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
204 | - | 1.15 % | $ 34.5 M | USA |
 |
CONMED Corporation
CNMD
|
57.3 | $ 35.66 | -2.67 % | $ 1.11 B | USA |
 |
Itamar Medical Ltd.
ITMR
|
131 | - | 0.03 % | $ 1.58 B |  Israel |
 |
NanoVibronix
NAOV
|
32.2 | - | - | $ 1.08 M | USA |
 |
Misonix, Inc.
MSON
|
83.1 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
48.6 | - | - | $ 111 M |  Canada |
 |
Intersect ENT, Inc.
XENT
|
72.8 | - | - | $ 955 M | USA |
 |
Electromed
ELMD
|
47.8 | $ 24.33 | -0.51 % | $ 206 M | USA |
 |
Cytosorbents Corporation
CTSO
|
125 | $ 0.59 | -1.62 % | $ 32.1 M | USA |
 |
Aethlon Medical
AEMD
|
61.8 | $ 2.21 | -2.64 % | $ 3.45 M | USA |
 |
Establishment Labs Holdings
ESTA
|
248 | $ 56.38 | -5.9 % | $ 1.67 B |  Costa-rica |
 |
PAVmed
PAVM
|
128 | $ 8.75 | -2.13 % | $ 63.3 M | USA |
 |
BIOLASE
BIOL
|
66.7 | - | -13.19 % | $ 166 K | USA |
 |
FONAR Corporation
FONR
|
16.6 | $ 18.54 | -0.03 % | $ 122 M | USA |
 |
InspireMD
NSPR
|
72.3 | $ 1.65 | -4.75 % | $ 106 M | Israel |
 |
Helius Medical Technologies
HSDT
|
362 | $ 1.92 | -4.48 % | $ 1.17 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
43.8 | $ 9.36 | -0.21 % | $ 721 M | USA |
 |
Inogen
INGN
|
34.6 | $ 6.3 | -3.08 % | $ 168 M | USA |
 |
AdaptHealth Corp.
AHCO
|
43.9 | $ 11.2 | -1.84 % | $ 1.51 B | USA |
 |
IRIDEX Corporation
IRIX
|
50.7 | $ 0.97 | -28.0 % | $ 15.6 M | USA |
 |
IRadimed Corporation
IRMD
|
34.8 | $ 97.63 | -1.12 % | $ 1.24 B | USA |
 |
Penumbra
PEN
|
26.1 | $ 335.13 | -0.38 % | $ 13 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
79.4 | $ 15.74 | -3.73 % | $ 369 M | USA |
 |
LivaNova PLC
LIVN
|
68 | $ 61.48 | -3.41 % | $ 3.35 B |  Britain |
 |
LENSAR
LNSR
|
66 | $ 5.59 | 1.27 % | $ 64.4 M | USA |